XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.2
COVER PAGE - USD ($)
 12 Months Ended
Dec. 31, 2022
Feb. 16, 2023
Jun. 30, 2022
Cover [Abstract]      
Document Type 10-K/A    
Document Annual Report true    
Document Period End Date Dec. 31, 2022    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 0-16211    
Entity Registrant Name DENTSPLY SIRONA Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 39-1434669    
Entity Address, Address Line One 13320 Ballantyne Corporate Place    
Entity Address, City or Town Charlotte    
Entity Address, State or Province NC    
Entity Address, Postal Zip Code 28277-3607    
City Area Code 844    
Local Phone Number 848-0137    
Title of 12(b) Security Common Stock, par value $.01 per share    
Trading Symbol XRAY    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 7,664,602,549
Entity Common Stock, Shares Outstanding   215,361,909  
Documents Incorporated by Reference DOCUMENTS INCORPORATED BY REFERENCECertain portions of the definitive Proxy Statement of DENTSPLY SIRONA Inc. (the “Proxy Statement”) to be used in connection with the 2023 Annual Meeting of Stockholders are incorporated by reference into Part III of this Form 10-K to the extent provided herein.    
Entity Central Index Key 0000818479    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Amendment Flag true    
Amendment Description EXPLANATORY NOTEDentsply Sirona Inc. (“Dentsply Sirona” or the “Company”) is filing this Amendment No. 1 to the Annual Report on Form 10-K (this “Form 10-K/A”) for the fiscal year ended December 31, 2022, originally filed with the Securities and Exchange Commission (the “SEC”) on March 1, 2023 (the “2022 Form 10-K” or “Original Filing”), to make certain changes described below.As previously disclosed in the Company’s Current Report on Form 8-K filed on August 2, 2023, subsequent to the issuance of the Company’s consolidated financial statements for the year ended December 31, 2022 which were included in the 2022 Form 10-K, the Company’s independent registered public accounting firm, PricewaterhouseCoopers LLP (“PwC”), conducted a routine internal quality review of its audit of the Company’s consolidated financial statements and internal control over financial reporting as of and for the year ended December 31, 2022. As a result of this review, PwC requested that the Company re-evaluate the conclusion on the assessment of a previously identified control deficiency related to segregation of duties specific to the creation of manual journal entries and compensating controls intended to mitigate a potential material impact to the consolidated financial statements as a result of such control deficiency. After extensive review, the Company and PwC have now determined that the control deficiency related to segregation of duties specific to the creation of manual journal entries rose to the level of a material weakness that existed as of December 31, 2022. The Company previously identified and reported in its 2022 Form 10-K other material weaknesses as part of Management’s Report on Internal Control Over Financial Reporting for the year ended December 31, 2022. To the knowledge of the Company’s principal executive officer and principal financial officer, the additional material weakness did not result in a material misstatement of the Company’s consolidated financial statements included in the 2022 Form 10-K. Notwithstanding the newly identified material weakness referred to above, management, including our principal executive officer and principal financial officer, believes that the financial statements contained in the 2022 Form 10-K continue to fairly present, in all material respects, the financial condition, results of operations and cash flows of the Company for all periods presented in accordance with generally accepted accounting principles in the United States.Amendment to Form 10-KIn accordance with Rule 12b-15 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), this Form 10-K/A is being filed to (i) amend Management’s Report on Internal Control Over Financial Reporting included in Part II, Item 8 to reflect the newly identified material weakness (ii) amend its disclosure on controls and procedures included in Part II, Item 9A, (iii) revise PwC’s integrated audit report thereon to disclose this additional material weakness as of December 31, 2022, and (iv) amend Part IV – Item 15 Exhibits and Financial Statement Schedules to include currently dated certifications from the Company’s Chief Executive Officer and Chief Financial Officer as required by Section 302 and 906 of the Sarbanes-Oxley Act of 2002. In amending Part II, Item 8, the Company also made one immaterial adjustment to disclosures contained within Note 2 - Revenue as described therein which does not otherwise impact or change the consolidated financial statements.Please note that the only changes to the Original Filing are those related to the matters described herein and only in the Items listed above. Except as described above, no changes have been made to the Original Filing, and this Form 10-K/A does not modify, amend or update any of the other financial information or other information contained in the Original Filing. In addition, in accordance with SEC rules, this Form 10-K/A includes an updated auditor consent as Exhibit 23.1 and updated certifications from our Chief Executive Officer and Chief Financial Officer as Exhibits 31.1, 31.2 and 32. Otherwise, the information contained in this Form 10-K/A is as of the date of the Original Filing and does not reflect any information or events occurring after the date of the Original Filing.